SeaStar Medical Holding Corporation Share Price
NASDAQ: ICU | Micro CapSeaStar Medical Holding Corporation Stock Performance
Open $3.43 | Prev. Close $3.27 | Circuit Range N/A |
Day Range $3.43 - $3.79 | Year Range $0.22 - $5.31 | Volume 2,503 |
Average Traded $3.70 |
SeaStar Medical Holding Corporation Share Price Today
As of 11 August 2026, SeaStar Medical Holding Corporation's share price is $3.68. The stock opened at $3.43, compared to its previous close of $3.27. During today's trading session, SeaStar Medical Holding Corporation's share price traded between $3.43 and $3.79, with an average price of $3.61. Over the past 52 weeks, the stock has recorded a high of $5.31 and a low of $0.22. In terms of performance, SeaStar Medical Holding Corporation's share price has risen by 36.55% over the last six months and is up 300.44% on a year-on-year basis.
SeaStar Medical Holding Corporation Share Price Chart
SeaStar Medical Holding Corporation Stock Fundamentals & Key Indicators
Market Cap $7.63M | PE Ratio (TTM) -0.63 | Dividend Yield N/A |
EPS (TTM) $-5.86 | Revenue (TTM) $1.23M | Return On Equity (TTM) -116.65% |
Profit Margin -984.60% | Debt to Equity 0.36 | Quarterly Earnings Growth YoY N/A |
SeaStar Medical Holding Corporation Quarterly Profit & Loss
All figures in USD
SeaStar Medical Holding Corporation Annual Profit & Loss
All figures in USD
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
SeaStar Medical Holding Corporation Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $3.18 | $3.68 | +16.83% |
Jul 2026 | $3.80 | $3.15 | -13.70% |
Jun 2026 | $3.71 | $3.65 | -1.08% |
May 2026 | $4.17 | $3.69 | -7.75% |
Apr 2026 | $3.55 | $4.00 | +5.82% |
Mar 2026 | $2.83 | $3.78 | +40.26% |
Feb 2026 | $2.40 | $2.69 | +13.24% |
Jan 2026 | $0.23 | $2.38 | +921.46% |
Dec 2025 | $0.30 | $0.23 | -25.32% |
Nov 2025 | $0.57 | $0.31 | -45.26% |
Oct 2025 | $0.56 | $0.57 | -1.04% |
Sep 2025 | $0.90 | $0.58 | -37.32% |
ICU Share Price FAQs
What is SeaStar Medical Holding Corporation share price today?
What is the 52 week high and 52 week low of SeaStar Medical Holding Corporation stock?
What is ICU's market capitalisation today?
What is ICU's net income for the last quarter?
What is the 5 year returns of ICU?
What is the high & low stock price of ICU today?
Can I buy ICU shares in India?